THERMEDICAL, INC.
WALTHAM, MA · CIK 0001544902 · Medtech · Private
Durablate® Catheter, a radiofrequency ablation device for treating ventricular tachycardia
- Grants
- $5.8M
- 5 awards
- Sector median: 1
- Raised
- $20M
- 7 Form D · Mar 2019
- 91 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 34
- 19 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,500,000 | |
| Private capital raised | Form D · SEC | $5,500,000 | |
| Private capital raised | Form D · SEC | $4,000,001 | |
| Private capital raised | Form D · SEC | $3,500,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Eliminating Ventricular Tachycardia: First in Human Clinical Trial using the Durablate™ Catheter | $1,673,144 | |
| Private capital raised | Form D · SEC | $2,250,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Eliminating Ventricular Tachycardia: First in Human Clinical Trial using the Durablate™ Catheter | $1,160,843 | |
| Private capital raised | Form D · SEC | $1,500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter | $1,342,339 | |
| Federal grant | Department of Health and Human Services · Phase II · Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter | $1,210,431 | |
| Federal grant | Department of Health and Human Services · Phase II · Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter | $437,984 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 972 | FOLDE INC | — | — |
| 973 | Lumina Diagnostics, Inc. | — | — |
| 974 | Hard 8 Games, LLC | — | $1.5M |
| 975 | THERMEDICAL, INC. | — | $20M |
| 976 | Hera Biotech, Inc. | — | $1.2M |
| 977 | Mila International Inc. | — | $2.0M |
| 978 | AAI Global Institutional LLC-S | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Michael CurleyDirector · Executive Officer
- Trena DepalExecutive Officer
- Patrick HamiltonDirector · Executive Officer
- Samuel MaslakDirector
- Roy TanakaDirector
Patents
- Devices And Methods For Delivering Fluid To Tissue During Ablation Therapyapplication
- Devices And Methods For Delivering Fluid To Tissue During Ablation Therapygranted
- Methods And Devices For Use Of Degassed Fluids With Fluid Enhanced Ablation Devicesapplication
- Inferred Maximum Temperature Monitoring For Irrigated Ablation Therapyapplication
- Methods And Devices For Use Of Degassed Fluids With Fluid Enhanced Ablation Devicesgranted
- Inferred Maximum Temperature Monitoring For Irrigated Ablation Therapygranted
- Methods And Devices For Controlling Ablation Therapygranted
- Devices And Methods For Remote Temperature Monitoring In Fluid Enhanced Ablation Therapyapplication
- Devices And Methods For Remote Temperature Monitoring In Fluid Enhanced Ablation Therapygranted
- Devices And Methods For Selectively Deploying Catheter Instrumentsapplication
- Methods And Devices For Use Of Degassed Fluids With Fluid Enhanced Ablation Devicesgranted
- Selectively Deployable Catheter Ablation Devicesgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.